Cytori Therapeutics Inc. (CYTX)
Symbol Info
Listed Symbol CYTX
Name Cytori Therapeutics Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $6,654,000
Latest Fiscal EPS $-1.76
Price Info
21 Day Moving Average $0.2376
21 Day EMA $0.234830
50 Day Moving Average $0.2455
50 Day EMA $0.246640
200 Day EMA $0.536790
200 Day Moving Average 0.294470
52 Week High $0.75
52 Week Low $0.20
52 Week Change $-67.602600
Alpha -0.095281
Beta 1.9212
Standard Deviation 0.275400
R2 0.058477
Periods 60
Share Information
10 Day Average Volume 699,993
20 Day Average Volume 914,309
30 Day Average Volume 813,225
50 Day Average Volume 651,803
Outstanding Shares 22,155,795
Float Shares 21,013,200
Percent Float 94.84%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 37
Institute Holdings Date 2019-06-30
Institute Bought Previous 3 Months 252,033
Institute Holdings Percent 2.800000
Institute Sold Previous 3 Months 70,104
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,142,595
Price Change
7 Day Price Change $-0.01751
7 Day Percent Change -12.55%
21 Day Price Change $-0.01491
21 Day Percent Change -11.58%
30 Day Price Change $-0.02521
30 Day Percent Change -15.29%
Month To Date Price Change $-0.0223
Month To Date Percent -14.28%
90 Day Price Change $-0.09151
90 Day Percent Change -33.32%
Quarter To Date $-0.02231
Quarter To Date Percent -14.28%
180 Day Price Change $-0.12801
180 Day Percent Change -40.32%
200 Day Price Change $-0.09001
200 Day Percent Change -33.00%
Year To Date $-0.07001
Year To Date Percent -28.38%
Profile
Description Cytori Therapeutics Inc is a specialty therapeutics company. It is committed to providing meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers around the world.
Details
Issue Type CS
Market Cap $4,601,759
Sec Type EQS
Auditor BDO USA, LLP
Total Shares Outstanding 22,155,795
CEO Marc H. Hedrick
Employees 37
Last Audit UE
Classification
CIK 0001095981
Industry Biotechnology
Sector Healthcare
NAICS Surgical and Medical Instrument Manufacturing(339112)
Info
Address 3020 Callan Road
San Diego, CA 92121
Website https://www.cytori.com
Facisimile
Telephone +1 858 458-0900
Email ir@cytori.com
Key Ratios
Profitability
EBIT Margin -145.2
EBITDA Margin -115
Pre-Tax Profit Margin -278
Profit Margin Cont -
Gross Margin 80.90
Profit Margin TOT -
Income Statements
Revenue $4,887,000
Revenue Per Share $0.2206
Revenue 3 Years $-20.44
Revenue 5 Years $-7.32
Valuation Measures
PE Ratio -
Enterprise Value $17,591,053
Price To Sales 0.997351
Price To Free Cash -0.6
PE High Last 5 Years -
Price To Book 1.3
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book -0.9
Financial Strength
Total Debt To Equity 4.3
Int Coverage -4.6
Current Ratio 0.5
Leverage Ratio 5.4
Quick Ratio 0.2
Long Term Debt To Capital 0.28
Assets
Receivables Turnover 21.4
Invoice Turnover 0.20
Assets Turnover 0.40
Management Effectiveness
Return Assets -56.71
Return On Equity -239.39
Return On Capital -53.81
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
CYTX
Cytori The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.